Acadia Pharmaceuticals ACAD Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Acadia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Acadia Pharmaceuticals's software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Acadia Pharmaceuticals's software and technology licenses, net?
- Acadia Pharmaceuticals (ACAD) reported software and technology licenses, net of $3.93M in Q1 2026.
- How has Acadia Pharmaceuticals's software and technology licenses, net changed year-over-year?
- Acadia Pharmaceuticals's software and technology licenses, net increased by 170.0% year-over-year, from $1.46M to $3.93M.
- What is the long-term trend for Acadia Pharmaceuticals's software and technology licenses, net?
- Over 5 years (2020 to 2025), Acadia Pharmaceuticals's software and technology licenses, net has grown at a 18.3% compound annual growth rate (CAGR), from $1.68M to $3.9M.